Rest Of Asia Pacific Prefilled Syringes Market (2026-2031)
The Rest Of Asia Pacific Prefilled Syringes Market was valued at $153.5 Million in 2026 and projected to reach to $220.6 Million by 2031, representing a compound annual growth rate of 7.5%. The Rest Of Asia Pacific prefilled syringes market is poised for steady growth through 2031, driven by expanding healthcare access and rising chronic disease management needs.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific Prefilled Syringes Market Trends and Insights
- Rest Of Asia Pacific is experiencing steady expansion driven by increasing healthcare infrastructure investments, rising chronic disease prevalence, and growing adoption of injectable biologics across emerging economies in the region.
- The market in Rest Of Asia Pacific benefits from improving regulatory frameworks and expanding pharmaceutical manufacturing capabilities that support prefilled syringe adoption. Rest Of Asia Pacific's prefilled syringes market is characterized by rising demand from both developed and developing healthcare systems seeking to enhance medication delivery efficiency and patient safety.
- Rest Of Asia Pacific manufacturers and distributors are increasingly focusing on cost-effective production and localized supply chains to meet regional demand.
- The forecast period through 2031 indicates sustained growth momentum in Rest Of Asia Pacific as healthcare providers prioritize convenient, pre-filled drug delivery solutions for chronic disease management and immunization programs..
Key Market Statistics
- CAGR (2026-2031) 7.5% CAGR
- Market Size, 2026 ~USD 153.5 Million
- Forecast, 2031 ~USD 220.6 Million
- Country Rest Of Asia Pacific
Rest Of Asia Pacific Prefilled Syringes Market Overview
Market Size & Growth :
Rest Of Asia Pacific prefilled syringes market valued at USD 153.5 million in 2026, expanding to USD 220.6 million by 2031 at a 7.5% CAGR, reflecting robust regional demand.
Healthcare Infrastructure Expansion :
Significant investments in healthcare infrastructure across emerging Asia Pacific nations are driving adoption of advanced drug delivery systems and prefilled syringe technologies.
Rising Chronic Disease Burden :
Increasing prevalence of diabetes, cancer, and autoimmune diseases in Rest Of Asia Pacific is accelerating demand for convenient, self-administered injectable therapies via prefilled syringes.
Biologics Adoption Growth :
Growing uptake of injectable biologics and biosimilars across Rest Of Asia Pacific markets is creating substantial opportunities for prefilled syringe manufacturers and suppliers.
Rest Of Asia Pacific Prefilled Syringes Market Dynamics
- Emerging economies in the region are increasingly adopting advanced pharmaceutical delivery systems as healthcare spending rises and patient awareness improves.
- The shift toward self-administered biologics and specialty pharmaceuticals is particularly strong, supported by improving cold chain infrastructure and regulatory frameworks.
- Government initiatives promoting healthcare modernization and pharmaceutical innovation are expected to further accelerate market penetration.
- Regional manufacturers are investing in capacity expansion and technology upgrades to meet growing demand..
Related Ecosystem
Key Takeaways
- Rest Of Asia Pacific prefilled syringes market valued at USD 153.5 million in 2026, expanding to USD 220.6 million by 2031 at 7.5% CAGR
- Rest Of Asia Pacific growth driven by rising chronic disease prevalence, healthcare infrastructure investment, and injectable biologic adoption across emerging economies
- Rest Of Asia Pacific market benefits from improving regulatory frameworks and localized manufacturing capabilities supporting regional supply chain development
- Rest Of Asia Pacific healthcare providers increasingly prioritize prefilled syringes for enhanced medication delivery efficiency, patient safety, and immunization program support
Prefilled Syringes Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SAFETY PREFILLED SYRINGES (Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 10.9% from 2026 to 2031 |
| Largest Segment | CONVENTIONAL PREFILLED SYRINGES (Type) |
| Market Size Base Year (Billions) | ~USD 8.66 (2026) |
| Revenue Forecast (Billions) | ~USD 14.53 (2031) |
| Segments Covered | Type, Design, Material, Application |
Rest Of Asia Pacific Prefilled Syringes Market Report Segmentation
4 segment dimensions are covered across the global market.
By Type
- Conventional Prefilled Syringes
- Disposable Prefilled Syringes
- Reusable Prefilled Syringes
- Safety Prefilled Syringes
By Design
- Customized Prefilled Syringes
- Dual-Chamber Prefilled Syringes
- Single-Chamber Prefilled Syringes
By Material
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
By Application
- Anaphylaxis
- Cancer
- Diabetes
- Ophthalmology
- Other Applications
- Rheumatoid Arthritis
- Thrombosis
Target Audience
- Pharmaceutical Manufacturers : Need regional market data to optimize product launches, assess demand for injectable formulations, and identify growth opportunities in Rest Of Asia Pacific's expanding biologics market.
- Medical Device Companies : Require detailed market insights to develop prefilled syringe solutions tailored to Rest Of Asia Pacific healthcare needs and regulatory requirements for competitive advantage.
- Healthcare Investors & PE Firms : Seek comprehensive market analysis to evaluate investment potential in Rest Of Asia Pacific prefilled syringe manufacturers and identify high-growth acquisition targets.
- Healthcare Providers & Hospital Networks : Need market intelligence to understand prefilled syringe availability, pricing trends, and supply chain dynamics in Rest Of Asia Pacific for procurement planning.
- Market Consultants & Analysts : Require region-specific data and forecasts to support client advisory work, competitive benchmarking, and strategic recommendations in Rest Of Asia Pacific healthcare markets.
Key Companies in the Rest Of Asia Pacific Prefilled Syringes Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Conventional prefilled syringe automation,Safety prefilled syringe automation,Glass prefilled syringe–focused systems, |
| CONSORT MEDICAL | United Kingdom | Private Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| HENRY SCHEIN | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| FLUOR CORPORATION | United States | Public Company | Conventional Prefilled Syringe Infrastructure,Safety Prefilled Syringe Infrastructure,Glass Prefilled Syringe Facilities, |
| MERIT MEDICAL | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| GUERBET GROUP | France | InvalidIdentifier | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| BECTON, DICKINSON AND COMPANY (BD) | United States | ||
| GERRESHEIMER AG | Germany | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| SCHOTT | Germany | Public Company | Glass prefilled syringes (syriQ, syriQ BioPure, silicone-free),Polymer prefilled syringes (TOPPAC portfolio),Cartridges (cartriQ, dual-chamber, large volume), |
| WEST PHARMACEUTICAL SERVICES, INC. | United States | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringe containment and components, |
| APTARGROUP, INC. | United States | Public Company | Conventional prefilled syringe components,Safety prefilled syringe and device-integrated systems,Glass prefilled syringe-related solutions, |
| NIPRO | Japan | Public Company | Glass Prefilled Syringe,Plastic Prefilled Syringe,Conventional Prefilled Syringe, |
| NOVARTIS AG | Switzerland | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringe, |
| STEVANATO GROUP | Italy | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| POLYMEDICURE | India | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| SHARPS TECHNOLOGY, INC. | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems for industrial applications.
CONSORT MEDICAL
Consort Medical is a United Kingdom-based private company established in 1938 with 2,000 employees. The company operates in the medical devices and pharmaceutical sectors.
HENRY SCHEIN
Henry Schein is a United States public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to dental, medical, and veterinary markets.
FLUOR CORPORATION
Fluor Corporation is a United States public company founded in 1912 with 22,995 employees. The company provides engineering, procurement, and construction services to the energy, chemicals, and infrastructure sectors.
MERIT MEDICAL
Merit Medical is a United States public company founded in 1987 with 7,500 employees. The company designs, manufactures, and distributes medical devices for interventional medicine and vascular access.
GUERBET GROUP
Guerbet Group is a French company in the medical imaging and pharmaceutical sectors. Specific operational details are unavailable.
BECTON, DICKINSON AND COMPANY (BD)
Becton, Dickinson and Company (BD) is a United States-based medical technology company. Specific founding date and employee count details are unavailable.
GERRESHEIMER AG
Gerresheimer AG is a German public company founded in 1864 with 13,528 employees. The company manufactures specialty glass and plastic products for the pharmaceutical and healthcare industries.
SCHOTT
Schott is a German public company founded in 1884 with 4,839 employees. The company produces specialty glass and glass-ceramic products for pharmaceutical, laboratory, and industrial applications.
WEST PHARMACEUTICAL SERVICES, INC.
West Pharmaceutical Services, Inc. is a United States public company founded in 1923 with 10,800 employees. The company manufactures packaging and delivery systems for injectable drugs and healthcare products.
APTARGROUP, INC.
AptarGroup, Inc. is a United States public company founded in 1992 with 14,000 employees. The company designs and manufactures dispensing systems and closures for the pharmaceutical, beauty, and food industries.
NIPRO
Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures and distributes medical devices, pharmaceuticals, and healthcare products globally.
NOVARTIS AG
Novartis AG is a Swiss public company founded in 1996 with 75,267 employees. The company is a global pharmaceutical and healthcare company developing innovative medicines and treatments.
STEVANATO GROUP
Stevanato Group is an Italian public company founded in 1949 with 6,010 employees. The company manufactures glass and plastic packaging solutions for the pharmaceutical industry.
POLYMEDICURE
Polymedicure is an Indian public company founded in 1995 with 3,082 employees. The company manufactures and distributes medical devices and healthcare products.
SHARPS TECHNOLOGY, INC.
Sharps Technology, Inc. is a United States public company founded in 2017. Specific employee count details are unavailable.
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations and growth projections specific to Rest Of Asia Pacific, enabling accurate business planning and investment decisions for this high-growth region.
- Growth Driver Analysis : Understand key factors fueling 7.5% CAGR in Rest Of Asia Pacific, including healthcare infrastructure investments, disease prevalence trends, and biologics adoption patterns unique to the region.
- Competitive Landscape Intelligence : Identify regional market players, competitive positioning, and strategic opportunities specific to Rest Of Asia Pacific prefilled syringe manufacturers and suppliers.
- Market Entry & Expansion Strategy : Develop informed go-to-market strategies for Rest Of Asia Pacific with insights on regulatory environments, distribution channels, and customer preferences across emerging economies.
- Investment & Partnership Opportunities : Discover high-potential investment targets and partnership opportunities in Rest Of Asia Pacific's growing prefilled syringe ecosystem through comprehensive market analysis.
Frequently asked questions
What is the market size of prefilled syringes in Rest Of Asia Pacific?
Rest Of Asia Pacific's prefilled syringes market is estimated at USD 153.5 million in 2026 and is projected to reach USD 220.6 million by 2031.
What is the expected growth rate for prefilled syringes in Rest Of Asia Pacific?
Rest Of Asia Pacific's prefilled syringes market is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2031.
What factors are driving growth in Rest Of Asia Pacific's prefilled syringes market?
Rest Of Asia Pacific's market growth is driven by increasing healthcare infrastructure investments, rising chronic disease prevalence, growing adoption of injectable biologics, improving regulatory frameworks, and expanding pharmaceutical manufacturing capabilities.
How is Rest Of Asia Pacific addressing prefilled syringe supply chain challenges?
Rest Of Asia Pacific manufacturers and distributors are focusing on cost-effective production methods and developing localized supply chains to meet regional demand and improve market accessibility.
What applications are driving prefilled syringe demand in Rest Of Asia Pacific?
Rest Of Asia Pacific healthcare providers are increasingly adopting prefilled syringes for chronic disease management, immunization programs, and injectable biologic delivery due to enhanced medication delivery efficiency and patient safety benefits.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the current prefilled syringes market size. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the prefilled syringes market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the prefilled syringes market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
A breakdown of the primary respondents for the prefilled syringes market is provided below:
**Others include sales, marketing, and product managers.
Note 1: C-level executives include CEOs, COOs, and CTOs.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the prefilled syringes market includes the following details.
The market sizing of the market was undertaken from the global side.
Country-level Analysis: The size of the prefilled syringes market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall prefilled syringes market was obtained from secondary data and validated by primary participants to arrive at the total prefilled syringes market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by prefilled syringes and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall prefilled syringes market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Prefilled Syringes Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Prefilled syringes are a convenient way to deliver parenteral medications or a single-dose packet of medication with a premeasured dose. This method of drug administration offers advantages for manufacturers in terms of reducing drug waste and extending product lifespan. Additionally, it provides ease of self-administration for patients at home and in non-hospital settings. Some examples of drugs packaged in prefilled syringes include biologics, vaccines, blood stimulants, therapeutic proteins, erythropoietin products, and interferons.
Key Stakeholders
- Product manufacturers, distributors, and suppliers
- Research laboratories
- Academic universities and medical research centers
- R&D centers
- Business research and consulting firms
- Biotechnology companies
- Hospitals
- Clinical centers
- Pharmaceutical companies
- Medical research laboratories
- Consulting firms
Report Objectives
- To describe, analyze, and forecast the prefilled syringes market by type, design, material, application, and region
- To describe and forecast the prefilled syringes market for key regions—North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the prefilled syringes market
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the prefilled syringes market
- To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the prefilled syringes market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
- Further breakdown of the Rest of Europe prefilled syringes market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
- Further breakdown of the Rest of Asia Pacific prefilled syringes market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
- Further breakdown of the Rest of Latin America prefilled syringes market into Colombia, Peru, and other countries.
Get the Full Prefilled Syringes Market Report
Full forecast, segment splits, and company analysis for all Prefilled Syringes Market.
- Canada Prefilled Syringes Market
- US Prefilled Syringes Market
- Germany Prefilled Syringes Market
- UK Prefilled Syringes Market
- France Prefilled Syringes Market
- Spain Prefilled Syringes Market
- Italy Prefilled Syringes Market
- Japan Prefilled Syringes Market
- China Prefilled Syringes Market
- India Prefilled Syringes Market
- Australia Prefilled Syringes Market
- South Korea Prefilled Syringes Market
- Brazil Prefilled Syringes Market
- Mexico Prefilled Syringes Market
- Argentina Prefilled Syringes Market
- GCC Countries Prefilled Syringes Market
- Rest Of Europe Prefilled Syringes Market
- Rest Of Latin America Prefilled Syringes Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report